Shanghai ordered vehicles off the road and factories to cut production after pollution reached hazardous levels, as Hong Kong announced plans to introduce an air quality index that assesses health risks from smog.
Let’s agree that 23andMe Inc., the Google-backed company marketing a $99 genetics test that assesses your risk for more than 240 health conditions, didn’t manage its relationship with the Food and Drug Administration well.
GlaxoSmithKline Plc’s much-maligned diabetes drug Avandia will be released from restrictions preventing sales to certain patients after U.S. regulators determined new data show the medicine doesn’t raise heart risks.
Activist funds, which buy stakes in companies in order to force changes in their operations, are one of the hottest trends in finance. Over the past year, the money flowing into them has surged so much that their assets under management are up more than 50 percent, while those of hedge funds as a whole have risen less than 15 percent.
Social theorists, above all Duke University’s Timur Kuran, have drawn attention to the phenomenon of “preference falsification.” The basic idea is that when people speak in public, they aren’t always truthful about their preferences. What they say is different from what they really think.